| Financial Year |
March 31 2023 |
| Monetary Funds |
345,922,316.38 |
| Held-for-trading Financial Assets |
5,000,000.00 |
| Notes Receivable |
87,481,286.54 |
| Accounts Receivable |
294,870,072.16 |
| Advances to Suppliers |
64,069,162.27 |
| Other Receivables |
4,308,216.32 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
317,438,740.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,779,410.33 |
| Total Current Assets |
1,276,420,063.94 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
72,453,047.39 |
| Investment Properties |
-- |
| Fixed Assetes |
59,102,154.42 |
| Under-construction Projects |
109,347,581.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
55,942,414.54 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
4,467,766.88 |
| Other Non-Current Assets |
39,195,428.40 |
| Sub-Total of Non-Current Assets |
340,508,393.23 |
| Total Assets |
1,616,928,457.17 |
| Short-Term Loans |
169,366,758.40 |
| Trading Financial liabilities |
-- |
| Notes Payable |
439,625,248.18 |
| Accounts Payable |
120,263,128.01 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,550,925.44 |
| Taxes Payable |
1,983,420.63 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
246,289.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
9,212,075.54 |
| Sub-Total of Current Liabilities |
755,864,023.32 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,890,457.11 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,890,457.11 |
| Total Liabilities |
757,754,480.43 |
| Paid-In Capital(Or Share Stock) |
100,000,000.00 |
| Capital Surplus |
441,826,419.40 |
| Surplus Reserve |
30,317,322.11 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
282,912,156.12 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
859,173,976.74 |
| Owner's Equity（Stockholder's Equity） |
859,173,976.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,616,928,457.17 |
